CAMP and Guillain-Barre syndrome: To examine whether cathelicidin deficiency was still protective in diabetes, WT and Camp−/− mice were treated with STZ and infected with GBS, and bladder burdens were compared to those of nondiabetic mice (values from the experiment shown in Fig. 3B).